StockVS

Hennessy Capital Investment Corp. VIII (HCICU) 股票分析

金融服务

Hennessy Capital Investment Corp. VIII

$10.04

+$0.00 (+0.00%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Hennessy Capital Investment Corp. VIII is a specialized entity focused on executing a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or a similar business combination with one or more businesses operating within the technology industry. The company operates within the Financial Services sector, specifically categorized under the industry of Shell Companies, which typically indicates a corporate structure formed primarily for the purpose of a future merger or acquisition rather than ongoing independent operations. Regarding its operational scale, the company has a market cap listed as N/A, with annual revenue figures also recorded as N/A, and the employee count is listed as N/A. The absence of defined market capitalization and revenue figures suggests that the entity functions as a pre-merger vehicle or a special purpose acquisition company (SPAC) where traditional valuation metrics and operational scale indicators have not yet been established through independent business activities.

财务健康

The financial statement for the trailing twelve months reports a net income of $-89,010, while revenue and EBITDA figures are listed as N/A. The significant negative net income in the absence of reported revenue indicates that the company is likely incurring substantial initial costs related to its formation and search for a target business, rather than generating profit from ongoing operations. Free cash flow is reported as N/A, which implies that the company currently lacks the positive cash generation required to fund capital expenditures or dividends without relying on external financing or asset monetization. The gross margin, operating margin, and profit margin are all recorded at 0.0%, reflecting the lack of revenue-generating activity typical for a shell company prior to its business combination. In terms of liquidity and leverage, the cash balance and total debt are both listed as N/A, while the debt-to-equity ratio is also unavailable, making it impossible to assess the company's current leverage position or balance sheet conservatism. The current ratio stands at 0.00, indicating that the company's current assets do not exceed its current liabilities, or that the data is insufficient to calculate a ratio greater than zero, suggesting potential short-term liquidity constraints typical of a pre-merger entity. Return on Equity and return on assets are both listed as N/A, meaning that there is no historical data available to evaluate management's effectiveness in generating profits from shareholders' equity or total assets at this stage of the company's lifecycle.

估值评估

The trailing P/E ratio and forward P/E ratio are both listed as N/A, as the company has not yet generated the sustained earnings necessary to calculate these metrics. The price-to-book ratio is recorded at -4980.00, a figure that is mathematically anomalous in standard equity valuation but indicates a severe disconnect between the market price and the company's book value, likely due to the negative net income and the nature of the shell company structure. Price-to-sales ratio and EV/EBITDA are also listed as N/A, suggesting that alternative valuation methods relying on revenue or earnings multiples cannot be applied to this specific entity at this time. The stock has exhibited price volatility with a 52-week high of $10.05 and a 52-week low of $9.92. Without a specific current share price provided in the data to perform a precise percentage calculation, the stock trades within a very narrow range relative to its 52-week high and low, indicating limited price movement over the past year. The beta value is listed as N/A, meaning that the company's price volatility relative to the broader market cannot be quantified due to insufficient trading data or market correlation history.

Growth & Income

The revenue growth year-over-year and earnings growth year-over-year are both listed as N/A, as the company has not yet completed the business combination required to establish a baseline for growth comparisons. Consequently, there is no data available to determine whether earnings growth would be outpacing or lagging revenue growth once the target acquisition is finalized. The company does not currently pay dividends, as the dividend yield and payout ratio are both listed as N/A, which is consistent with the capital allocation strategy of SPACs and shell companies that reinvest all available capital into identifying and acquiring a target business rather than distributing income to shareholders. The overall growth and income profile of Hennessy Capital Investment Corp. VIII is currently undefined, characterized by the absence of historical earnings, dividend distributions, and growth rates until the company executes its planned merger with a technology sector business.

同行比较

Hennessy Capital Investment Corp. VIII (HCICU) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Hennessy Capital Investment Corp. VIII HCICU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。Hennessy Capital Investment Corp. VIII的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Hennessy Capital Investment Corp. VIII

Hennessy Capital Investment Corp. VIII focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses in technology industry. The company was incorporated in 2025 and is based in Zephyr Cove, Nevada.

公司简介以英文显示。

访问官网 →

关键指标

市值
N/A
市盈率
N/A
52周最高
$10.27
52周最低
$9.80
平均成交量
33.99K

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States